70399-02-9Relevant academic research and scientific papers
Visible-light-driven electron donor-acceptor complex induced sulfonylation of diazonium salts with sulfinates
Cheng, Lan,Guo, Jianbo,Li, Yufei,Liang, Xin,Wang, Qingmin,Xia, Qing,Zhang, Pei,Zhang, Weihua
supporting information, p. 8865 - 8870 (2021/11/30)
This work reports an efficient sulfonylation reaction enabled by a visible-light-induced radical coupling reaction between phenyl/heterocyclic diazonium salts and sulfinates. Mechanistic experiments disclosed the formation of a versatile electron donor-acceptor (EDA) complex. This transformation is characterized by an easy operational procedure under mild conditions which avoids transition metals, ligands, catalysts, and oxidants.
Preparation method of 4-isopropylsulfonylphenylboronic acid
-
, (2021/04/26)
The invention discloses a preparation method of 4-isopropylsulfonylphenylboronic acid, and belongs to the technical field of organic synthesis. The preparation method comprises the following steps of: taking 4-bromothiophenol and halogenated isopropane as the raw materials, and acquiring 1-bromo-4-isopropyl thiobenzene under the action of potassium carbonate; performing oxidizing with hydrogen peroxide in the presence of a catalyst to obtain 1-bromo-4-isopropylsulfonylbenzene, and finally, carrying out Grignard exchange/borate reaction with a Grignard reagent to obtain 4-isopropylsulfonylphenylboronic acid. The method has the advantages of high yield, simple process, cheap and easily available raw materials, green chemistry, and 6 times of application of the catalyst, and has an industrial amplification prospect.
DI-SUBSTITUTED PYRAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES
-
Paragraph 00256; 00259; 00260, (2018/03/28)
Provided herein are compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds and compositions in treating a condition, disease, or disorder associated with abnormal activation of the SREBP pathway, including meta
11,21-BISPHENYL-19-NORPREGNANE DERIVATIVES
-
, (2008/06/13)
The invention relates to a 11,21-bisphenyl-19-norpregnane derivative of formula I STR1 wherein R 1 is selected from H, halogen, (1-6C) alkoxy, and NR 5 R 6, R 5 and R 6 being independently hydrogen or (1-6C)alkyl or R 5 and R 6 together are (3-6C) alkylen
